Group 1 - LLLT for Weight Loss

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Weight Loss+2 More
Low Level Laser Therapy - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether low-level laser therapy, used along with lifestyle changes, can help people lose weight in the central body region.

Eligible Conditions
  • Weight Loss
  • Obesity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 weeks

6 weeks
Amount of fat mass loss

Trial Safety

Trial Design

2 Treatment Groups

Group 1 - LLLT
1 of 2
Group 2 - SHAM
1 of 2

Active Control

Non-Treatment Group

60 Total Participants · 2 Treatment Groups

Primary Treatment: Group 1 - LLLT · Has Placebo Group · N/A

Group 2 - SHAM
Other
ShamComparator Group · 1 Intervention: Sham (placebo) · Intervention Types: Other
Group 1 - LLLT
Device
ActiveComparator Group · 1 Intervention: Low Level Laser Therapy · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 weeks

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,896 Previous Clinical Trials
3,699,261 Total Patients Enrolled
18 Trials studying Weight Loss
1,168 Patients Enrolled for Weight Loss
Erchonia CorporationIndustry Sponsor
38 Previous Clinical Trials
1,835 Total Patients Enrolled
1 Trials studying Weight Loss
Ivana T Croghan, PhDPrincipal InvestigatorProfessor of Medicine, College of Medicine
5 Previous Clinical Trials
249 Total Patients Enrolled
1 Trials studying Weight Loss
60 Patients Enrolled for Weight Loss
Ryan T Hurt, MD, PhDStudy DirectorMayo Clinic
3 Previous Clinical Trials
395 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a BMI of 25-39.9 kg/m2.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 16th, 2021

Last Reviewed: November 9th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.